IRulya Therapeutics (IRLA) Cash & Current Investments (2018 - 2026)
IRulya Therapeutics' Cash & Current Investments was $116 million in Q2 2026, up 234.2% from $34.71 million a year earlier and up 537.4% from the prior quarter.
IRulya Therapeutics (IRLA) Cash & Current Investments (2018 - 2026) Analysis & Trends
At the end of FY2025, Cash & Current Investments at IRulya Therapeutics came in at $17.75 million, down 56.5% from FY2024.
- Cash & Current Investments has now declined for five consecutive years, with a five-year compound annual growth rate of -33.2% (FY2020 to FY2025).
- In earlier years, Cash & Current Investments was $40.78 million in FY2024 (-45.7%), $75.06 million in FY2023 (-16.8%), $90.18 million in FY2022 (-15.6%) and $106.8 million in FY2021 (-20.2%).
- The Q2 2026 figure marks the highest quarterly Cash & Current Investments since Q2 2021.
- Compared with a year earlier, Cash & Current Investments was higher in 1 of the last eight quarters, with an average decline of 11.6%.
- The best year-over-year quarter for Cash & Current Investments over five years was Q2 2026 (growth of 234.2%); the worst was Q4 2025 (a decline of 56.5%).
- Per Business Quant data, IRLA's Cash & Current Investments in the three quarters before Q2 2026 was $18.2 million (Q1 2026), $17.75 million (Q4 2025) and $26.29 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | 505.00 Mn |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 14.27 Bn |
| 10 | IRulya Therapeutics | 207.35 Mn | 91.35 Mn | - | 116.00 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 116.00 Mn |
| Mar 31, 2026 | 18.20 Mn |
| Dec 31, 2025 | 17.75 Mn |
| Sep 30, 2025 | 26.29 Mn |
| Jun 30, 2025 | 34.71 Mn |
| Mar 31, 2025 | 31.60 Mn |
| Dec 31, 2024 | 40.78 Mn |
| Sep 30, 2024 | 47.85 Mn |
| Jun 30, 2024 | 59.45 Mn |
| Mar 31, 2024 | 67.82 Mn |
| Dec 31, 2023 | 75.06 Mn |
| Sep 30, 2023 | 83.23 Mn |
| Jun 30, 2023 | 87.57 Mn |
| Mar 31, 2023 | 90.20 Mn |
| Dec 31, 2022 | 90.18 Mn |
| Sep 30, 2022 | 94.34 Mn |
| Jun 30, 2022 | 94.66 Mn |
| Mar 31, 2022 | 91.52 Mn |
| Dec 31, 2021 | 106.80 Mn |
| Sep 30, 2021 | 114.41 Mn |
IRulya Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=IRLA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "IRLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=IRLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();